Azerbaijan: Avian flu highlights poor diagnostic capacity:
This article was originally published in Clinica
Executive Summary
The health ministry of Azerbaijan has called on the World Health Organization to help it investigate a cluster of 11 suspected avian flu cases, including at least three deaths. The WHO's involvement has highlighted shortcomings in the country's diagnostic services and supplies. "The response of the health ministry has been prompt and efficient, but hampered by the lack of some essential equipment and supplies, and an inadequate diagnostic capacity. The WHO is this week sending a team of experts, laboratory equipment and diagnostic reagents to the country. In the meantime, samples of the cases reported to date have been sent to the WHO laboratory in the UK.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.